Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    

VUMC Seeks Plasma Donations from Recovered COVID-19 Patients


April 14, 2020 - Vanderbilt University Medical Center is recruiting volunteers who have tested positive for COVID-19 and fully recovered to donate plasma to help those who are currently ill with the virus as part of a new research study.

People who have fully recovered from COVID-19 have antibodies in their plasma that can attack the virus. Convalescent plasma is being evaluated as treatment for patients with serious or immediately life-threatening COVID-19 infections, or those judged by a health care provider to be at high risk of progression to severe or life-threatening disease.

"There have been reports coming out of other countries that convalescent plasma is beneficial for other patients. What Vanderbilt University Medical Center wants to do is demonstrate in a randomized control fashion that truly is the case as opposed to just anecdotal evidence," said Allison Wheeler, MD, assistant professor of Pathology and Pediatrics and principal investigator of the plasma collection arm of the study.

"The goal of our trial is truly understanding if this treatment is beneficial for patients with this infection. By studying outcomes, we can learn what could help all people with COVID-19, not just our current patients, and help people in the future know more about the use of immune plasma in treatment."

Vanderbilt's three-part convalescent plasma research program includes identifying patients who have had COVID-19 infections and who have survived; collecting plasma from people who have a high antibody titer (a strong immune response); and treating patients who currently have COVID-19. The first two parts are launching now

The inclusion criteria includes volunteers who tested positive for COVID-19, recovered, and are at least 14 days from a negative COVID-19 test; patients who tested positive and are at least 28 days free of symptoms but haven't had a negative COVID-19 test; and patients who had clinical symptoms but have never been tested for COVID. They will be tested to prove they have it.

Additionally, volunteers will need to meet the general FDA guidelines on blood donation to screen for infectious diseases and risk factors.

One unit of donated plasma has the potential to help four patients, Wheeler said. The donation procedure takes approximately one to two hours.

The VUMC convalescent plasma study is hoping to enroll 250 volunteers.

If you are interested in learning whether you meet the criteria to donate convalescent plasma, please visit and


Related Articles:

Recent Articles

New Study Looks at Cost Impact of OTC Birth Control

A new study explores the impact on unintended pregnancies, consistent use of progestin-only OTC birth control pills at various price points.

Read More

Behavioral Health in a Time of Social Isolation

Last month, the Nashville Health Care Council brought together experts for a virtual panel discussion on behavioral health in the midst of social distancing orders.

Read More

COVID-19 & Mental Health

As the virus takes its toll, providers are finding new ways to reach patients and preparing for the mental health fallout ahead.

Read More

Self-Care on the Front Lines of Coronavirus

Physicians, nurses, respiratory therapists and the full complement of support staff at hospitals and clinics are battling coronavirus on the front lines. When caring for others, it's all too easy to forget to take care of yourself.

Read More

Sharing Best Practices in Behavioral Health

Nashville-based online video service provides evidence-based training to public and providers.

Read More

May is Mental Health Month

May is Mental Health Month with excellent resources from national organizations for both patients and providers.

Read More

Business Insights

Read More

Celebrating 15 Years of Incredible Leaders

Following are the 15 classes of Women to Watch. Some of these trailblazers have happily retired after a career of service. Others have moved to other positions and taken up new challenges since they were first recognized.

Read More

New Study Looks at Cost Impact of OTC Birth Control

A new study explores the impact on unintended pregnancies, consistent use of progestin-only OTC birth control pills at various price points.

Read More

AHA Releases Scientific Statement on CAD with Type 2 Diabetes

A new AHA scientific statement explores more aggressive clinical options for the patient-centered management of individuals with both type 2 diabetes and coronary artery disease.

Read More

Email Print



Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: